Skip to main content
Clinical Trials/ISRCTN05214203
ISRCTN05214203
Completed
Not Applicable

A prospective Longitudinal trial of the effect of Atomoxetine on cognitive, educational, behavioural, social and emotional wellbeing in students with Attention Deficit Hyperactivity Disorder

Australian Research Council (Australia)0 sites144 target enrollmentNovember 20, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
Australian Research Council (Australia)
Enrollment
144
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Boys and girls aged seven to 15 years
  • 2\. Meet the Diagnostic and Statistical Manual of Mental Disorders \- Fourth Edition (DSM\-IV) criteria for ADHD, as determined by the referring paediatrician or child psychiatrist
  • 3\. Participants are naive to atomoxetine medication

Exclusion Criteria

  • 1\. A history of bipolar or psychotic disorder
  • 2\. Tourette?s syndrome
  • 3\. Substance abuse
  • 4\. Serious medical illness
  • 5\. Intellectual disability (Intelligence Quotient \[IQ] less than 70\)
  • 6\. Pregnancy
  • 7\. Non compliance with research protocol

Outcomes

Primary Outcomes

Not specified

Similar Trials